-
2
-
-
34250213660
-
Bortezomib-induced paralytic ileus is a potential gastrointestinal side effect of this first-in-class anticancer proteasome inhibitor
-
V Perfetti G Palladini L Brunetti A Sgarella S Brugnatelli PG Gobbi GR Corazza 2007 Bortezomib-induced paralytic ileus is a potential gastrointestinal side effect of this first-in-class anticancer proteasome inhibitor Eur J Gastroenterol Hepatol 19 7 599 601
-
(2007)
Eur J Gastroenterol Hepatol
, vol.19
, Issue.7
, pp. 599-601
-
-
Perfetti, V.1
Palladini, G.2
Brunetti, L.3
Sgarella, A.4
Brugnatelli, S.5
Gobbi, P.G.6
Corazza, G.R.7
-
3
-
-
33947492500
-
Mucositis in patients with hematologic malignancies: An overview
-
P Niscola C Romani L Cupelli L Scaramucci A Tendas T Dentamaro S Amadori P de Fabritiis 2007 Mucositis in patients with hematologic malignancies: an overview Haematologica 92 2 222 231
-
(2007)
Haematologica
, vol.92
, Issue.2
, pp. 222-231
-
-
Niscola, P.1
Romani, C.2
Cupelli, L.3
Scaramucci, L.4
Tendas, A.5
Dentamaro, T.6
Amadori, S.7
De Fabritiis, P.8
-
4
-
-
20044381304
-
SUMMIT/CREST Investigators. Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function
-
S Jagannath B Barlogie JR Berenson S Singhal R Alexanian G Srkalovic RZ Orlowski PG Richardson J Anderson D Nix DL Esseltine KC Anderson 2005 SUMMIT/CREST Investigators. Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function Cancer 103 6 1195 1200
-
(2005)
Cancer
, vol.103
, Issue.6
, pp. 1195-1200
-
-
Jagannath, S.1
Barlogie, B.2
Berenson, J.R.3
Singhal, S.4
Alexanian, R.5
Srkalovic, G.6
Orlowski, R.Z.7
Richardson, P.G.8
Anderson, J.9
Nix, D.10
Esseltine, D.L.11
Anderson, K.C.12
-
5
-
-
31444442200
-
A practical update on the use of bortezomib in the management of multiple myeloma
-
J San Miguel J Bladé M Boccadoro J Cavenagh A Glasmacher S Jagannath S Lonial RZ Orlowski P Sonneveld H Ludwigj 2006 A practical update on the use of bortezomib in the management of multiple myeloma Oncologist 11 51 61
-
(2006)
Oncologist
, vol.11
, pp. 51-61
-
-
San Miguel, J.1
Bladé, J.2
Boccadoro, M.3
Cavenagh, J.4
Glasmacher, A.5
Jagannath, S.6
Lonial, S.7
Orlowski, R.Z.8
Sonneveld, P.9
Ludwigj, H.10
-
6
-
-
34249102599
-
Pseudomembranous colitis following Bortezomib therapy in a myeloma patient
-
S-J Moon C-K Min D-G Lee S Lee J-W Lee W-S Min C-C Kim M Kim G Park Y Kim 2007 Pseudomembranous colitis following Bortezomib therapy in a myeloma patient Acta Haematol 117 211 214
-
(2007)
Acta Haematol
, vol.117
, pp. 211-214
-
-
Moon, S.-J.1
Min, C.-K.2
Lee, D.-G.3
Lee, S.4
Lee, J.-W.5
Min, W.-S.6
Kim, C.-C.7
Kim, M.8
Park, G.9
Kim, Y.10
-
7
-
-
34249983437
-
Chemotherapy-induced mucositis: The role of gastrointestinal microflora and mucins in the luminal environment
-
AM Stringer RJ Gibson JM Bowen RM Logan AS Yeoh DM Keefe 2007 Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment J Support Oncol 5 6 259 267
-
(2007)
J Support Oncol
, vol.5
, Issue.6
, pp. 259-267
-
-
Stringer, A.M.1
Gibson, R.J.2
Bowen, J.M.3
Logan, R.M.4
Yeoh, A.S.5
Keefe, D.M.6
-
8
-
-
33747364771
-
Cancer chemotherapy-induced diarrhoea and constipation: Mechanisms of damage and prevention strategies
-
RJ Gibson DM Keefe 2006 Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies Support Care Cancer 14 9 890 900
-
(2006)
Support Care Cancer
, vol.14
, Issue.9
, pp. 890-900
-
-
Gibson, R.J.1
Keefe, D.M.2
-
9
-
-
33745107459
-
Intestinal mucositis: The role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage
-
JM Bowen RJ Gibson AG Cummins DM Keefe 2006 Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage Support Care Cancer 14 7 713 731
-
(2006)
Support Care Cancer
, vol.14
, Issue.7
, pp. 713-731
-
-
Bowen, J.M.1
Gibson, R.J.2
Cummins, A.G.3
Keefe, D.M.4
|